The implantable cardioverter–defibrillator (ICD) reduces cardiac mortality among patients at risk for ventricular arrhythmias. 1,2 Transvenous ICD implantation may be complicated by vascular ...

The implantable cardioverter-defibrillator (ICD) has been shown to decrease the risk of sudden cardiac death in patients when used for primary and secondary prevention. These devices are being ...

Treatment with amiodarone or an implantable cardioverter–defibrillator (ICD) has been proposed to improve the prognosis in such patients. We randomly assigned 2521 patients with New York Heart ...

Targeted ICD selection based on predicted therapy benefit enhances patient outcomes while cutting hospital costs by 16.7%.

Few medical therapies pose the issue of how to avoid sudden cardiac death as starkly as does the implantable cardioverter defibrillator — a device that is implanted like a pacemaker, which has been ...

New York, Sept. 27, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Market.us, the Global Implantable Cardioverter Defibrillator Market size is expected to be worth around USD 7.7 Billion ...

Vancouver, Oct. 19, 2023 (GLOBE NEWSWIRE) -- The global Implantable Cardioverter Defibrillator (ICD) market size is expected to reach USD 9.80 Billion at a steady CAGR of 2.7% in 2032, according ...

More than three decades have transpired since the inception of transtelephonic pacemaker monitoring. 1 3 This modality was identified as a useful method for tracking the function of pacemaker ...

Background: Although more than 150,000 implantable cardioverter defibrillators (ICDs) are implanted yearly worldwide, only few studies systematically examined complications of ICD therapy in large ...

New research from the University of Minnesota Medical School demonstrates that using cardiovascular magnetic resonance imaging—known as CMR phenotyping—can help identify patients with suspected ...